361 related articles for article (PubMed ID: 30484744)
1. Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant
Choi JH; Seong GM; Ko Y; Kim YR; Kim C
Microb Drug Resist; 2019 May; 25(4):577-581. PubMed ID: 30484744
[No Abstract] [Full Text] [Related]
2. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
[TBL] [Abstract][Full Text] [Related]
3. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.
Waites KB; Ratliff A; Crabb DM; Xiao L; Qin X; Selvarangan R; Tang YW; Zheng X; Dien Bard J; Hong T; Prichard M; Brooks E; Dallas S; Duffy L; Mixon E; Fowler KB; Atkinson TP
J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31484701
[TBL] [Abstract][Full Text] [Related]
4. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430
[TBL] [Abstract][Full Text] [Related]
5. Macrolide resistance of
Jiang Y; Dou H; Xu B; Xu B; Zhou W; Wang H; Ge L; Hu Y; Han X; Qin X; Li J; Ye L; Wu L; Zuo H; Zhang Q; Liu L; Hu W; Shao J; Yin Q; Han L; Fu X; Dong X; Dong Y; Fu Y; Zhao M; Sun Q; Huo J; Liu D; Liu W; Li Y; Wang Y; Xin D; Shen K
Epidemiol Infect; 2024 Apr; 152():e75. PubMed ID: 38634450
[TBL] [Abstract][Full Text] [Related]
6. Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.
Miyashita N; Oka M; ; Kawai Y; Yamaguchi T; Ouchi K
Int J Antimicrob Agents; 2010 Oct; 36(4):384-5. PubMed ID: 20674283
[No Abstract] [Full Text] [Related]
7. Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance.
Yoo SJ; Kim HB; Choi SH; Lee SO; Kim SH; Hong SB; Sung H; Kim MN
Antimicrob Agents Chemother; 2012 Dec; 56(12):6393-6. PubMed ID: 23006753
[TBL] [Abstract][Full Text] [Related]
8. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.
Miyashita N; Kawai Y; Akaike H; Ouchi K; Hayashi T; Kurihara T; Okimoto N;
BMC Infect Dis; 2012 May; 12():126. PubMed ID: 22650321
[TBL] [Abstract][Full Text] [Related]
9. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011.
Hong KB; Choi EH; Lee HJ; Lee SY; Cho EY; Choi JH; Kang HM; Lee J; Ahn YM; Kang YH; Lee JH
Emerg Infect Dis; 2013 Aug; 19(8):1281-4. PubMed ID: 23876792
[TBL] [Abstract][Full Text] [Related]
10. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.
Ho PL; Law PY; Chan BW; Wong CW; To KK; Chiu SS; Cheng VC; Yam WC
J Clin Microbiol; 2015 Nov; 53(11):3560-4. PubMed ID: 26338857
[TBL] [Abstract][Full Text] [Related]
11. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.
Cao B; Qu JX; Yin YD; Eldere JV
Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811
[TBL] [Abstract][Full Text] [Related]
12. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
Lung DC; Chan YH; Kwong L; Que TL
Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
[TBL] [Abstract][Full Text] [Related]
13. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.
Morozumi M; Iwata S; Hasegawa K; Chiba N; Takayanagi R; Matsubara K; Nakayama E; Sunakawa K; Ubukata K;
Antimicrob Agents Chemother; 2008 Jan; 52(1):348-50. PubMed ID: 17954691
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014.
Kogoj R; Mrvic T; Praprotnik M; Kese D
Euro Surveill; 2015; 20(37):. PubMed ID: 26536357
[TBL] [Abstract][Full Text] [Related]
15. A study of community-acquired
Yu HX; Zhao MM; Pu ZH; Ju YR; Liu Y
Colomb Med (Cali); 2018 Jun; 49(2):160-163. PubMed ID: 30104808
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China.
Qu J; Chen S; Bao F; Gu L; Cao B
Int J Infect Dis; 2019 Jun; 83():26-31. PubMed ID: 30926541
[TBL] [Abstract][Full Text] [Related]
17. First Description of Macrolide-Resistant
Loconsole D; De Robertis AL; Mallamaci R; Sallustio A; Morea A; Prato R; Quarto M; Martinelli D; Chironna M
Biomed Res Int; 2019; 2019():7168949. PubMed ID: 31008110
[TBL] [Abstract][Full Text] [Related]
18. First Detection and Characterization of Macrolide-Resistant
Noori Goodarzi N; Pourmand MR; Arfaatabar M; Azimi G; Masoorian E; Rahimi Foroushani A; Aminharati F; Heidarzadeh S; Baghani A
Microb Drug Resist; 2020 Mar; 26(3):245-250. PubMed ID: 31545147
[No Abstract] [Full Text] [Related]
19. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009.
Suzuki Y; Itagaki T; Seto J; Kaneko A; Abiko C; Mizuta K; Matsuzaki Y
Pediatr Infect Dis J; 2013 Mar; 32(3):237-40. PubMed ID: 23114374
[TBL] [Abstract][Full Text] [Related]
20. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
Tanaka T; Oishi T; Miyata I; Wakabayashi S; Kono M; Ono S; Kato A; Fukuda Y; Saito A; Kondo E; Teranishi H; Tanaka Y; Wakabayashi T; Akaike H; Ogita S; Ohno N; Nakano T; Terada K; Ouchi K
Emerg Infect Dis; 2017 Oct; 23(10):1703-1706. PubMed ID: 28930026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
